These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27509825)

  • 1. The matricellular ligand Cyr61 contributes to the metastatic spread of tumors by activating integrin VLA-4, independently of thiol redox modulation
.
    Hoß SG; Schlesinger M; Bendas G
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):682-685. PubMed ID: 27509825
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
    Schmitz P; Gerber U; Schütze N; Jüngel E; Blaheta R; Naggi A; Torri G; Bendas G
    Thromb Haemost; 2013 Nov; 110(5):1046-54. PubMed ID: 24009013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation.
    Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC
    Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state.
    Layani-Bazar A; Skornick I; Berrebi A; Pauker MH; Noy E; Silberman A; Albeck M; Longo DL; Kalechman Y; Sredni B
    Cancer Res; 2014 Jun; 74(11):3092-103. PubMed ID: 24699624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.
    Schlesinger M; Bendas G
    Cancer Metastasis Rev; 2015 Dec; 34(4):575-91. PubMed ID: 25564456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
    Fritzsche J; Simonis D; Bendas G
    Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization.
    Chigaev A; Smagley Y; Sklar LA
    BMC Immunol; 2014 Oct; 15():52. PubMed ID: 25367365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding between heparin and the integrin VLA-4.
    Schlesinger M; Simonis D; Schmitz P; Fritzsche J; Bendas G
    Thromb Haemost; 2009 Nov; 102(5):816-22. PubMed ID: 19888514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
    Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
    Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
    Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
    Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between molecular and cellular dissociation rates for VLA-4/VCAM-1 interaction in the absence of shear stress.
    Zwartz G; Chigaev A; Foutz T; Larson RS; Posner R; Sklar LA
    Biophys J; 2004 Feb; 86(2):1243-52. PubMed ID: 14747358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of monocytes to periodontal fibroblasts requires activation of NOD1/2- and TLR4-mediated LFA-1 and VLA-4.
    Liu J; Liu W; Xie Y; Wang Y; Ouyang X
    Arch Oral Biol; 2015 Jun; 60(6):834-44. PubMed ID: 25791323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives.
    Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G
    Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression.
    Huang YT; Lan Q; Ponsonnet L; Blanquet M; Christofori G; Zaric J; Rüegg C
    Oncotarget; 2016 Jan; 7(2):1663-74. PubMed ID: 26625209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
    Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
    J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Anticancer Activity of Organotelluranes: Potential Role in Integrin Inactivation.
    Silberman A; Kalechman Y; Hirsch S; Erlich Z; Sredni B; Albeck A
    Chembiochem; 2016 May; 17(10):918-27. PubMed ID: 26991356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin.
    Chigaev A; Waller A; Zwartz GJ; Buranda T; Sklar LA
    J Immunol; 2007 Jun; 178(11):6828-39. PubMed ID: 17513731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
    Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
    Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flt3-ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)-4- and VLA-5-dependent mechanism.
    Solanilla A; Grosset C; Duchez P; Legembre P; Pitard V; Dupouy M; Belloc F; Viallard JF; Reiffers J; Boiron JM; Coulombel L; Ripoche J
    Br J Haematol; 2003 Mar; 120(5):782-6. PubMed ID: 12614209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.